May 1, 2026 Log in

News

BRIM Biotechnology Reports May 2026 Revenue of NT$0.82 Million, Down 27.9% YoY

Citation-Grade Primary-source linked Schema.org verified NQ 26 / 100

Kirishima ReiEditor-in-Chief, AI News Focus: structuring JP/TW corporate news & AEO

Published May 1, 2026 9:00 AM ・ Updated Jun 14, 2026 12:09 AM ・ 2 min read ・ Source: PR Times

Show contents

⚡ Key Points

NT$0.01 billion), representing a year-on-year decrease of 27.9%.

BRIM Biotechnology (6885) announced its consolidated revenue for May 2026 at NT$822,000 (approx. NT$0.01 billion), representing a year-on-year decrease of 27.9%.

PRIMARY SOURCE PR Times View source Distributor: PR Times
Published: May 1, 2026

Company Code: 6885 Company Name: BRIM Biotechnology Industry: Biotechnology and Medical Data Month/Year: 2026-05 Monthly Revenue: NT$822 thousand (approx. NT$0.01 billion) YoY Change: -27.9%

Keywords: Monthly Revenue, Biotechnology and Medical Industry

FACT BOX

Source: PR Times
Category: News

Editorial & Verification Standards

The Washin AI News desk structures and reviews this article under the following standards.

Start only from primary sources (official PR, disclosures, wire services)
Numbers and proper nouns machine-checked against the source (number-completeness check)
Company names and tickers verified via registry (Registry/TWSE/Wikidata)
No speculation; nothing stated that is not in the source

Read the full editorial policy →

Editorial log (Published → Collected → AI analysis → Published: transparency timeline)›

Announced　May 1, 2026 9:00 AM — Distributor PR Times
Collected　Jun 12, 2026 8:00 AM
AI structured & analyzed　Jun 12, 2026 1:51 PM
Desk-reviewed & published　May 1, 2026 9:00 AM

FAQ

What is BRIM Biotechnology's revenue for May 2026?

BRIM Biotechnology reported a revenue of NT$822,000 for May 2026, which is a decrease of 27.9% compared to the same month last year.

What is the stock code of BRIM Biotechnology?

The stock code is 6885 on the Taiwan stock market, classified under the Biotechnology and Medical industry.

Why is BRIM Biotechnology's monthly revenue so low?

As an early-stage drug development company, it has no commercialized products yet, leading to minimal and volatile monthly revenues.

Cite this article — HOW TO CITE

Washin AI News Desk“BRIM Biotechnology Reports May 2026 Revenue of NT$0.82 Million, Down 27.9% YoY”AI News by Washin Village（和心村）, May 1, 2026. https://aeo.washinmura.jp/ai/%E5%85%A8%E7%A6%8F%E7%94%9F%E6%8A%80/en/news/2026-05-01-%E5%85%A8%E7%A6%8F%E7%94%9F%E6%8A%80-2026-05-%E6%9C%88%E7%87%9F%E6%94%B6-0-01%E5%84%84-%E5%B9%B4%E5%A2%9E-27-9

AI CRAWLER ACTIVITY

as of Jul 3, 2026

AI crawler visits to this article (cumulative)Measuring since publication (no visits recorded yet)

Site-wide cumulative

ClaudeBot

bot_visits_summary

5014k

last Jul 3, 2026

GPTBot

bot_visits_summary

3367k

last Jul 3, 2026

Bingbot

bot_visits_summary

2063k

last Jul 3, 2026

Google AI

bot_visits_summary

1807k

last Jul 3, 2026

Googlebot

bot_visits_summary

1323k

last Jul 3, 2026

Applebot

bot_visits_summary

1126k

last Jul 3, 2026

※ Only measured values from bot_visits_summary / crawler_url_hits are shown. Article-level zero counts are shown as measuring.

Washin AI News（AI News by Washin Village（和心村））

An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.

Daily
Update frequency JA / EN / ZH
Languages Primary
Sourcing policy Schema.org
Structured verification

About the publisher IDA llms.txt

Get your announcement indexed as AI-citable structured news.
Primary-source links, three languages, Schema.org verified.Talk to us about coverage →

← 全福生技 Back to newsroom (65)

Copied